# US-China Summit, SCOTUS on Abortion Drug, El Niño’s Status and more Page: https://stenobird.com/podcast/cnn-5-things-716851/us-china-summit-scotus-on-abortion-drug-el-ni-o-s-status-and-more Text version: https://stenobird.com/podcast/cnn-5-things-716851/us-china-summit-scotus-on-abortion-drug-el-ni-o-s-status-and-more.md Podcast: [CNN 5 Things](https://stenobird.com/podcast/cnn-5-things-716851) Published: 2026-05-14T21:53:00+00:00 Episode link: https://www.podtrac.com/pts/redirect.mp3/pdst.fm/e/swap.fm/track/2nzGkisFXQswLYT5s325/traffic.megaphone.fm/WMHY9091988888.mp3?updated=1778795548 Audio file: https://www.podtrac.com/pts/redirect.mp3/pdst.fm/e/swap.fm/track/2nzGkisFXQswLYT5s325/traffic.megaphone.fm/WMHY9091988888.mp3?updated=1778795548 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/cnn-5-things-716851/episodes/us-china-summit-scotus-on-abortion-drug-el-ni-o-s-status-and-more Duration seconds: 399 ## Resource We start with the latest takeaways from President Donald Trump’s high-stakes meeting in China today. We’ll tell you where access to an abortion pill stands. High-profile turnover in the Trump administration continues. A new measure is set to take effect after the midterms that affects senators’ pay. Plus, a warning from forecasters could impact your summer. Learn more about your ad choices. Visit podcastchoices.com/adchoices ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/cnn-5-things-716851/episodes/us-china-summit-scotus-on-abortion-drug-el-ni-o-s-status-and-more/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/cnn-5-things-716851/us-china-summit-scotus-on-abortion-drug-el-ni-o-s-status-and-more.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.